These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9975)

  • 1. Effects of iodination of tyrosyl residues on the binding and action of glucagon at its receptor.
    Lin MC; Nicosia S; Rodbell M
    Biochemistry; 1976 Oct; 15(20):4537-40. PubMed ID: 9975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodoglucagon. Preparation and characterization.
    Desbuquois B
    Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase.
    Wright DE; Rodbell M
    J Biol Chem; 1979 Jan; 254(2):268-9. PubMed ID: 216670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GTP on binding of (3H) glucagon to receptors in rat hepatic plasma membranes.
    Lin MC; Nicosia S; Lad PM; Rodbell M
    J Biol Chem; 1977 Apr; 252(8):2790-2. PubMed ID: 16000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane receptor function and the loss of glucagon-stimulated adenylate cyclase activity in hepatomas.
    Mirel RD; Morris HP; DiAugustine RP
    Endocrinology; 1978 Apr; 102(4):1237-46. PubMed ID: 217618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes.
    Mason JC; Tager HS
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6835-9. PubMed ID: 2995990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of glucagon receptors in Morris hepatoma 7800.
    Mourelle M; Rojkind M
    Hepatology; 1984; 4(3):515-9. PubMed ID: 6327489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational determinants in receptor recognition of peptide hormones: interaction of parathyroid hormone with the glucagon receptor.
    Shah GV; Epand RM; Orlowski RC
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):203-10. PubMed ID: 3030852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
    Lin MC; Wright DE; Hruby VJ; Rodbell M
    Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of insulin and glucagon binding and the adenylate cyclase response in liver membranes of the prenatal, postnatal, and adult rat: evidence of glucagon "resistance".
    Blazquez E; Rubalcava B; Montesano R; Orci L; Unger RH
    Endocrinology; 1976 Apr; 98(4):1014-23. PubMed ID: 179786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of glucagon in isolated liver endosomes. ATP-dependence and partial characterization of degradation products.
    Authier F; Desbuquois B
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):211-8. PubMed ID: 1741749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
    Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase.
    Bataille D; Freychet P; Rosselin G
    Endocrinology; 1974 Sep; 95(3):713-21. PubMed ID: 4368831
    [No Abstract]   [Full Text] [Related]  

  • 20. The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.
    Houslay MD; Metcalfe JC; Warren GB; Hesketh TR; Smith GA
    Biochim Biophys Acta; 1976 Jun; 436(2):489-94. PubMed ID: 179598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.